{"doi":"10.1002\/ptr.2794","coreId":"136835","oai":"oai:bradscholars.brad.ac.uk:10454\/4536","identifiers":["oai:bradscholars.brad.ac.uk:10454\/4536","10.1002\/ptr.2794"],"title":"Anti-inflammatory properties of cryptolepine.","authors":["Olajide, O. A.","Ajayi, A. A.","Wright, Colin W."],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2010-12-07T14:10:08Z","abstract":"noCryptolepine is the major alkaloid of the West African shrub, Cryptolepis sanguinolenta. Cryptolepine has\\ud\nbeen shown to inhibit nitric oxide production, and DNA binding of Nuclear Factor-kappa B following\\ud\ninflammatory stimuli in vitro. In order to validate the anti-inflammatory property of this compound in vivo,\\ud\nwe investigated its effects on a number of animal models of inflammation. Cryptolepine (10\u00bf40 mg\/kg i.p.)\\ud\nproduced significant dose-dependent inhibition of the carrageenan-induced rat paw oedema, and carrageenaninduced\\ud\npleurisy in rats. These effects were compared with those of the non-steroidal anti-inflammatory drug\\ud\nindomethacin (10 mg\/kg). At doses of 10\u00bf40 mg\/kg i.p., cryptolepine inhibited lipopolysaccharide (LPS)-induced\\ud\nmicrovascular permeability in mice in a dose-related fashion. Oral administration of up to 40 mg\/kg of the\\ud\ncompound for four consecutive days did not induce gastric lesion formation in rats. Analgesic activity was also\\ud\nexhibited by cryptolepine through a dose-related (10\u00bf40 mg\/kg i.p.) inhibition of writhing induced by i.p.\\ud\nadministration of acetic acid in mice. The results of this study reveal that cryptolepine possesses in vivo\\ud\nanti-inflammatory activity.Copyright \u00a9 2009 John Wiley & Sons, Ltd","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"John Wiley & Sons","rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:bradscholars.brad.ac.uk:10454\/4536<\/identifier><datestamp>\n                2016-08-18T17:17:43Z<\/datestamp><setSpec>\n                com_10454_152<\/setSpec><setSpec>\n                col_10454_6342<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nAnti-inflammatory properties of cryptolepine.<\/dc:title><dc:creator>\nOlajide, O. A.<\/dc:creator><dc:creator>\nAjayi, A. A.<\/dc:creator><dc:creator>\nWright, Colin W.<\/dc:creator><dc:subject>\nCryptolepine<\/dc:subject><dc:subject>\nCryptolepis sanguinolenta<\/dc:subject><dc:subject>\nAnti-inflammatory properties<\/dc:subject><dc:subject>\nAnalgesic<\/dc:subject><dc:description>\nno<\/dc:description><dc:description>\nCryptolepine is the major alkaloid of the West African shrub, Cryptolepis sanguinolenta. Cryptolepine has\\ud\nbeen shown to inhibit nitric oxide production, and DNA binding of Nuclear Factor-kappa B following\\ud\ninflammatory stimuli in vitro. In order to validate the anti-inflammatory property of this compound in vivo,\\ud\nwe investigated its effects on a number of animal models of inflammation. Cryptolepine (10\u00bf40 mg\/kg i.p.)\\ud\nproduced significant dose-dependent inhibition of the carrageenan-induced rat paw oedema, and carrageenaninduced\\ud\npleurisy in rats. These effects were compared with those of the non-steroidal anti-inflammatory drug\\ud\nindomethacin (10 mg\/kg). At doses of 10\u00bf40 mg\/kg i.p., cryptolepine inhibited lipopolysaccharide (LPS)-induced\\ud\nmicrovascular permeability in mice in a dose-related fashion. Oral administration of up to 40 mg\/kg of the\\ud\ncompound for four consecutive days did not induce gastric lesion formation in rats. Analgesic activity was also\\ud\nexhibited by cryptolepine through a dose-related (10\u00bf40 mg\/kg i.p.) inhibition of writhing induced by i.p.\\ud\nadministration of acetic acid in mice. The results of this study reveal that cryptolepine possesses in vivo\\ud\nanti-inflammatory activity.Copyright \u00a9 2009 John Wiley & Sons, Ltd.<\/dc:description><dc:date>\n2010-12-07T14:10:08Z<\/dc:date><dc:date>\n2010-12-07T14:10:08Z<\/dc:date><dc:date>\n2010-12-07T14:10:08Z<\/dc:date><dc:type>\nArticle<\/dc:type><dc:type>\nNo full-text available in the repository<\/dc:type><dc:identifier>\nOlajide, O. A., Ajayi, A. A. and Wright, C. W. (2009). Anti-inflammatory properties of cryptolepine. Phytotherapy Research. Vol. 23, No. 10, pp. 1421\u00bf1425.<\/dc:identifier><dc:identifier>\n90010329<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/10454\/4536<\/dc:identifier><dc:language>\nen<\/dc:language><dc:relation>\nhttp:\/\/dx.doi.org\/10.1002\/ptr.2794<\/dc:relation><dc:publisher>\nJohn Wiley & Sons<\/dc:publisher>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":null,"language":null,"relations":["http:\/\/dx.doi.org\/10.1002\/ptr.2794"],"year":2010,"topics":["Cryptolepine","Cryptolepis sanguinolenta","Anti-inflammatory properties","Analgesic"],"subject":["Article","No full-text available in the repository"],"fullText":null}